B. Wirleitner et al., 7,8-DIHYDRONEOPTERIN-INDUCED APOPTOSIS IN JURKAT T-LYMPHOCYTES - A COMPARISON WITH ANTI-FAS-MEDIATED AND HYDROGEN PEROXIDE-MEDIATED CELL-DEATH, Biochemical pharmacology, 56(9), 1998, pp. 1181-1187
Activated cell-mediated immunity, associated for example with HIV infe
ction, is accompanied by elevated concentrations of neopterin and 7,8-
dihydroneopterin. Recent data have indicated a role of neopterin deriv
atives in virus activation and apoptotic cell death, processes likely
to involve the action of oxygen free radicals. Because T cell death in
AIDS is likely to involve the Fas/Fas ligand system and the action of
oxygen free radicals and 7,8-dihydroneopterin, we compared the kineti
cs and sensitivity of apoptotic cell death of human leukemic Jurkat T
cells to that of treatments with 7,8-dihydroneopterin, anti-Fas, and H
2O2. Upon incubation with 5 mM 7,8-dihydroneopterin and 50 mu M hydrog
en peroxide over a period of 24 hr, bimodal kinetics were observed wit
h peaks at 5.5 hr (7,8-dihydroneopterin, 13.1%; H2O2, 11.4%) and at 24
hr (7,8-dihydroneopterin, 11.2%; H2O2, 13.2%). In contrast, anti-Fas
(20 ng/mL)-induced apoptosis increased steadily over time, peaking at
11 hr (43.2%). Interestingly, anti-Fas-induced apoptosis was suppresse
d upon co incubation with 7,8-dihydroneopterin and H2O2 by 62% and 68%
, respectively. We also compared the sensitivity to drug treatments of
apoptosis induced by 7,8-dihydroneopterin, anti-Fas antibodies, and H
2O2 7,8-dihydroneopterin-mediated, and similarly anti-Fas- and H2O2-me
diated, apoptosis was not inhibited by a broad range of pharmacologica
l inhibitors, such as actinomycin D, cycloheximide, cyclosporin A, and
various protein kinase inhibitors. On the contrary, inhibitors with a
ntioxidant abilities, such as pyrrolidinedithiocarbamate, significantl
y blocked 7,8-dihydroneopterin-, H2O2- as well as anti-Fas-mediated ap
optosis. These results imply that 7,8-dihydroneopterin-, H2O2-, and an
ti-Fas-mediated cell death might involve related redox sensitive signa
l transduction pathways. (C) 1998 Elsevier Science Inc.